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SUMMARY Mooren's ulcer is a chronic, painful corneal ulceration of unknown aetiology. Recent histological and immunological studies suggest an autoimmune basis. It is now becoming clear that the immune system plays an intricate role in maintaining homoeostasis in health and disease. Regulation of the immune response appears to involve a subset of peripheral blood T lymphocytes known as suppressor cells. A qualitative or quantitative deficiency of suppressor cells may therefore be responsible for chronic inflammation, autoimmune disease, and immunodeficiency states. To explain the reported immunological aberrations the number of suppressor T cells in addition to other immunological parameters were studied in a patient with bilateral Mooren's ulcers. A deficiency of suppressor T cells was found in the peripheral blood. This deficit in the immunoregulatory mechanism explains some of the immunological abnormalities reported in previous studies. Furthermore this study provides additional evidence for an autoimmune aetiology. In the light of these findings the possibility of a new line of treatment has been raised.
Mooren's ulcer' is a chronic, painful ulceration of the cornea that begins in the periphery with a steep, undermined, leading edge. The ulcer spreads first circumferentially and then centrally to involve the whole cornea. It is bilateral in approximately 25% of cases but does not necessarily develop simultaneously in both eyes. An unequivocal cause has not been established for this progressive and relentless condition, but an autoimmune aetiology is strongly suspected.
Inflammation is essentially a protective response to minimise the effect of injuries-microbiological, immunological, or otherwise. In certain individuals the inflammatory response may, however, outlive its useful purpose. Failure to 'switch-off' certain inflammatory responses beyond their purposeful existence represents a weakness in the regulatory mechanism in the immune response involving a subset of peripheral blood lymphocytes, known as suppressor cells. It has been suggested that patients having a qualitative or quantitative deficiency of this suppressor machinery are more prone to chronic inflammation2 and autoimmune disease.3
Correspondence to Dr P. I. Murray, Department of Pathology, Institute of Ophthalmology, [17] [18] [19] [20] [21] [22] [23] [24] [25] Cayton Street, London, EC1V 9AT. Developments in the field of cellular immunology are now constantly illuminating the complex functions of lymphocytes in humoral and cell-mediated immunity. With the advent ofmonoclonal antibodies4 the role of T-cell subsets,5 especially helper and suppressorT-cells, has been made clearer. Imbalances of the helper/suppressor ratio have increased our understanding of immune regulation in various disease processes.
Peripheral blood lymphocytes consist of 3 distinct cell populations:
(1) B (unpublished observation) . Abnormalities of the helper/suppressor ratio have also been found in patients with Graves' ophthalmopathy,'6 and recurrent herpes simplex keratitis. '7 As previous studies'8-26 have suggested an autoimmune basis for Mooren's ulcer, it was decided therefore to investigate subsets of peripheral T lymphocytes and other immunological parameters in a 67-year-old man suffering from bilateral Mooren's ulcers.
Case report
A 67-year-old man developed soreness and irritation of his left eye in June 1981. There was no history of injury. On examination his visual acuities were 6/5 right, 6/6 left, and he had a left corneal ulcer involving the inferotemporal periphery. He was initially treated with a topical steroid and antibiotic combination, which had little effect. Over the next few months the ulcer became more painful and progressed relentlessly despite the addition of systemic indomethacin to the above medication. In May 1982 he underwent a left conjunctival resection combined with cryotherapy, but the ulcer advanced progressively, and in December 1982 a left total tarsorrhaphy was performed.
In January 1982 he developed a painful ulcer in the inferotemporal periphery of his right cornea. This initially responded well to a right conjunctival resection and cryotherapy performed in March 1982. Unfortunately his right eye flared up 4 months later, and a further conjunctival resection and cryotherapy were undertaken. In December 1982, after another flare-up, a right conjunctival flap was fashioned in the inferotemporal quadrant. In February 1983 he was admitted for investigation. On admission his right visual acuity was 6/5, his left visual acuity was perception of light only. His medication was guttae Predsol-N (prednisolone and neomycin) 4 times daily to the right eye, indomethacin slow release 75 mg once daily, and propranolol 40 mg twice daily. The last drug was for hypertension, which had been diagnosed 5 years earlier. During his stay in hospital he was found to have diabetes mellitus and was started on glibenclamide 2-5 mg twice daily.
Materials and methods

MEASUREMENT OF T CELLS (E ROSETTES)
AND THEIR SUBSETS 19 were unable to demonstrate autoantibody to cornea or conjunctiva but noted blastogenic transformation and proliferation of lymphocytes by extracts of normal corneal stroma. Although they used both human and xenogeneic tissues in their studies, it is not clear whether both types of extract were used.
Wood and Kaufman28 and later Tabbara and Ostler20 described 2 clinical types of Mooren's ulcer: (a) Old patients with males predominant (3:2), and having no predilection for race; 25% of cases are bilateral, with moderate to severe pain, and pursue a slow and relentless course. Their prognosis is fair and they rarely perforate. (b) Young patients with males predominant (3:1); blacks are frequently affected.
The cases are usually bilateral (75%), with variable amounts of pain, and have a rapid progression. The prognosis is poor; one-third perforate, and trauma is a predisposing factor.
From our case history our patient fits into category (a), and our findings in this patient are similar to those in previous studies-namely, raised serum IgA, and the detection of autoantibody to cornea and conjunctiva. It must be stated, however, that autoantibody to cornea and conjunctiva was detected only on xenogeneic substrate (Fig. 1) ; we were unable to confirm this on human substrate. The 4 possibilities for this inconsistency are: (1) Rat cornea and conjunctiva as compared with human substrate may have a higher concentration of tissue-specific antigens which are located at more accessible positions. (2) The human substrate used was not fresh but one week old, and although it was refrigerated the possibility exists that some of the antigens might have been lost. (3) The reaction involved nonspecific antibodies cross-reacting with transplantation and other xenogeneic antigens. (4) The antibodies in the patient's serum were specific but of low affinity and therefore possibly reacted only with xenogeneic substrate.
The most significant finding (in our study) was a decrease in suppressor T cells, causing an increase in the helper/suppressor ratio. This has not been reported before. The total number of E-rosetting T cells, however, were within normal limits. One of the recent advances in immunology is the elucidation of a very important although complex core regulatory circuit (Fig. 2) which modulates the immune responses and regulates the biological outcome. Applying this concept to chronic inflammatory disorders of the eye we can explain most of the immunological aberrations found in Mooren's ulcer on the basis of a reduction of suppressor T cells as seen in the present case.
The immune system29 is an intricate network homoeostatically balanced by positive and negative internal signals or messages passing between the different subsets of lymphocytes. These subsets differ in their surface membrane characterstics as well as their roles; some induce, others regulate, or may act as effector cells in the immune response. The current model of induction and modulation of the immune response requires recognition of antigen on the surface of the macrophage by precursors of thymusderived helper T cells. The next event is the release of a soluble factor, interleukin 1, from the macrophage, which acts on the precursor helper T cell causing release of a second factor, interleukin 2. The pre- The treatment of Mooren's ulcer, either medical29 or surgical,30 is usually unsatisfactory. Possibly a new line of treatment with one of the thymic hormones may be of value in the future. Five groups of hormones have so far been isolated from or originate in the thymus.31 These are thymosin, thymopoietin, thymic humoral factor, thymostimulin, and thymic serum factor. As stated previously T lymphocytes differentiate and mature under the influence of the thymus, and so far thymosin has been used clinically only in diseases with low T-cell (E-rosette) levels,32-35 such as immunodeficiency states, SLE, and some types of cancer, as it has the ability to increase the number of E-rosetting cells. Ahmed et al. 36 have also shown that thymosin can induce suppressor cells in vitro. Although our patient had normal E-rosetting values, it is possible that the use of thymosin in Mooren's ulcer could increase the number of suppressor cells, thereby correcting the defect in the core regulatory circuit, thus preventing further tissue damage. Another drug worth mentioning is cyclosporin A, a metabolic product of soil fungi, that has been used successfully in renal allografting. Its mode of action is unclear but it does increase the number of suppressor cells.3" Early reports of its use on patients with posterior uveitis38 have been encouraging, though renal toxicity has not yet been excluded as few long-term studies have been carried out. They are certainly possibilities worth considering.
In conclusion, the immunological abnormalities found in Mooren's ulcer may be due to an underlying defect in the complex immune regulatory system caused by a reduction in the number of suppressor T lymphocytes. In view of this finding it is tempting to speculate that a new line of treatment using thymosin or cyclosporin A may be worthwhile in this serious, sight-threatening condition.
